PAVmed (PAVM) Revenue & Revenue Breakdown
PAVmed Revenue Highlights
Latest Revenue (Y)
$71.00M
Latest Revenue (Q)
$22.00M
Main Segment (Y)
Royalty
PAVmed Revenue by Period
PAVmed Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $71.00M | 2270.62% |
| 2024-12-31 | $3.00M | 22.15% |
| 2023-12-31 | $2.45M | 550.40% |
| 2022-12-31 | $377.00K | -24.60% |
| 2021-12-31 | $500.00K | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | - |
PAVmed generated $71.00M in revenue during NA 2025, up 2270.62% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
PAVmed Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $22.00M | 42207.69% |
| 2025-12-31 | $52.00K | 940.00% |
| 2025-09-30 | $5.00K | -16.67% |
| 2025-06-30 | $6.00K | -25.00% |
| 2025-03-31 | $8.00K | -20.00% |
| 2024-12-31 | $10.00K | -99.00% |
| 2024-09-30 | $996.00K | 1.74% |
| 2024-06-30 | $979.00K | -3.07% |
| 2024-03-31 | $1.01M | -3.72% |
| 2023-12-31 | $1.05M | 32.62% |
| 2023-09-30 | $791.00K | 376.51% |
| 2023-06-30 | $166.00K | -62.78% |
| 2023-03-31 | $446.00K | 298.21% |
| 2022-12-31 | $112.00K | 47.37% |
| 2022-09-30 | $76.00K | 100.00% |
| 2022-06-30 | - | -100.00% |
| 2022-03-31 | $189.00K | -37.00% |
| 2021-12-31 | $300.00K | 50.00% |
| 2021-09-30 | $200.00K | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | - |
PAVmed generated $22.00M in revenue during Q1 2026, up 42207.69% compared to the previous quarter, and up 220000.00% compared to the same period a year ago.
PAVmed Revenue Breakdown
PAVmed Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 |
|---|---|---|
| Royalty | $100.00M | $100.00M |
Latest
PAVmed's latest annual revenue breakdown by segment (product or service), as of Dec 22: Royalty (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 23 | Dec 22 | Mar 22 |
|---|---|---|---|
| Royalty | $10.00K | - | $100.00M |
| Minimum Annual Royalty Fee | - | - | $100.00M |
Latest
PAVmed's latest quarterly revenue breakdown by segment (product or service), as of Jun 23: Royalty (100.00%).
PAVmed Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Mar 22 |
|---|---|
| Minimum Annual Royalty Fee | $100.00M |
| Royalty | $100.00M |
Latest
PAVmed's latest quarterly revenue breakdown by geography, as of Mar 22: Minimum Annual Royalty Fee (50.00%), and Royalty (50.00%).
PAVmed Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BNR | Burning Rock Biotech | $537.43M | $125.62M |
| PAVM | PAVmed | $71.00M | $22.00M |
| DHAI | DIH US | $62.86M | $19.81M |
| SSKN | STRATA Skin Sciences | $30.70M | $6.93M |
| BMRA | Biomerica | $5.42M | $987.00K |
| TNON | Tenon Medical | $3.94M | $1.38M |
| PTHL | Pheton Ltd Class A Ordinary Shares | $448.20K | $118.85K |
| HSCS | HeartSciences | $18.60K | - |
| IINN | Inspira Technologies Oxy B.H.N. | - | - |
| ADVB | Advanced Biomed | - | - |
| APVO | Aptevo Therapeutics | - | - |